NHC director sells 7,500 shares in open market
NATIONAL HEALTHCARE CORP director Richard F. LaRoche Jr. reported an open-market sale of 7,500 shares of common stock at $195.1421 per share.
Accepted by SEC EDGAR
Learn about SEC filing dates
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
NATIONAL HEALTHCARE CORP director Richard F. LaRoche Jr. reported an open-market sale of 7,500 shares of common stock at $195.1421 per share. After this sale, he directly holds 205,760 common shares, indicating he retains a substantial equity position.
In addition to these shares, he holds multiple option awards covering 7,500 underlying shares each from grants dated 2022 through 2026, with exercise prices ranging from $55.75 to $171.42 and expirations between 2027 and 2031. No derivative options were exercised in this filing.
Insider Trade Summary
Net Seller: 7,500 shares
Net Sell
1 txn
Insider
LAROCHE RICHARD F JR
Role
Director
Sold
7,500 shs ($1.46M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock - Held in my name or my wife's name | 7,500 | $195.1421 | $1.46M |
| Holding | Option to Purchase Common Stock [2022 Grant] | -- | -- | -- |
| Holding | Option to Purchase Common Stock [2023 Grant] | -- | -- | -- |
| Holding | Option to Purchase Common Stock [2024 Grant] | -- | -- | -- |
| Holding | Option to Purchase Common Stock [2025 Grant] | -- | -- | -- |
| Holding | Option to Purchase Common Stock [2026 Grant] | -- | -- | -- |
Holdings After Transaction:
Common Stock - Held in my name or my wife's name — 205,760 shares (Direct);
Option to Purchase Common Stock [2022 Grant] — 7,500 contracts (Direct);
Option to Purchase Common Stock [2023 Grant] — 7,500 contracts (Direct);
Option to Purchase Common Stock [2024 Grant] — 7,500 contracts (Direct);
Option to Purchase Common Stock [2025 Grant] — 7,500 contracts (Direct);
Option to Purchase Common Stock [2026 Grant] — 7,500 contracts (Direct)
Key Figures
Shares sold: 7,500 shares
Sale price per share: $195.1421 per share
Shares held after sale: 205,760 shares
+5 more
8 metrics
Shares sold
7,500 shares
Open-market sale of NHC common stock
Sale price per share
$195.1421 per share
Price for 7,500 NHC shares sold
Shares held after sale
205,760 shares
Direct NHC common stock ownership following transaction
2026 option exercise price
$171.4200
Option to purchase 7,500 NHC shares, expires 2031
2025 option exercise price
$94.6600
Option to purchase 7,500 NHC shares, expires 2030
2024 option exercise price
$96.0300
Option to purchase 7,500 NHC shares, expires 2029
2023 option exercise price
$55.7500
Option to purchase 7,500 NHC shares, expires 2028
2022 option exercise price
$69.1900
Option to purchase 7,500 NHC shares, expires 2027
Key Terms
open-market sale, Option to Purchase Common Stock, exercise price, expiration date, +1 more
5 terms
open-market sale financial
"Sale in open market or private transaction"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Option to Purchase Common Stock financial
"Option to Purchase Common Stock [2026 Grant]"
exercise price financial
"conversion_or_exercise_price": "171.4200""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date": "2031-05-06T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
underlying security financial
"underlying_security_title": "Common Stock""
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did NHC director Richard F. LaRoche Jr. report?
Richard F. LaRoche Jr., a director of NATIONAL HEALTHCARE CORP (NHC), reported an open-market sale of 7,500 shares of common stock at $195.1421 per share. This Form 4 filing records the transaction and his updated ownership position in the company.
At what price did Richard F. LaRoche Jr. sell NHC common stock?
Richard F. LaRoche Jr. sold 7,500 shares of NATIONAL HEALTHCARE CORP common stock at $195.1421 per share. This per-share price comes directly from the Form 4 transaction details describing the open-market sale of the non-derivative common stock.
What stock options on NHC does Richard F. LaRoche Jr. hold according to this Form 4?
He holds options from 2022–2026 grants, each for 7,500 underlying NHC common shares. Exercise prices range from $55.75 to $171.42, with expiration dates running from 2027 through 2031, indicating multiple unexercised derivative positions remaining after this transaction.
Were any NHC stock options exercised in this Form 4 filing?
No stock options were exercised in this filing. The Form 4 lists several option grants as holdings with future exercise and expiration dates, while the only reported transaction is an open-market sale of 7,500 non-derivative common shares held directly.
Is the reported NHC insider transaction a buy or a sell?
The reported transaction is a sale. Richard F. LaRoche Jr. executed an open-market sale of 7,500 NATIONAL HEALTHCARE CORP common shares, as indicated by transaction code “S” and the transaction description stating a sale in the open market.
AI-generated analysis. How Rhea-AI works. Not financial advice.
